2023 - Research.com Medicine in Canada Leader Award
2003 - Fellow of the Royal Society of Canada Academy of Science
1997 - Léo-Pariseau Prize, Association francophone pour le savoir (Acfas)
The scientist’s investigation covers issues in Endocrinology, Internal medicine, Receptor, Neuroscience and Neuropeptide Y receptor. His work on Endocrinology deals in particular with Hippocampus, Central nervous system, Hippocampal formation, Cholinergic and Nucleus accumbens. His Receptor research is multidisciplinary, incorporating perspectives in Olfactory bulb and Binding site.
His Neuroscience study combines topics in areas such as Neuropeptide and Pathogenesis. His Neuropeptide Y receptor study incorporates themes from Elevated plus maze and Inhibitory postsynaptic potential. Within one scientific family, he focuses on topics pertaining to Nitric oxide under Biochemistry, and may sometimes address concerns connected to Pharmacology.
Rémi Quirion mainly focuses on Internal medicine, Endocrinology, Receptor, Neuroscience and Neuropeptide Y receptor. His work in Acetylcholine, Neuropeptide, Muscarinic acetylcholine receptor, Agonist and Cholinergic is related to Internal medicine. His studies in Endocrinology integrate themes in fields like Calcitonin gene-related peptide and Binding site.
His Binding site research is multidisciplinary, incorporating elements of Biophysics and Pharmacology. To a larger extent, Rémi Quirion studies Biochemistry with the aim of understanding Receptor. His biological study spans a wide range of topics, including Hypothalamus and Antagonist.
His scientific interests lie mostly in Endocrinology, Internal medicine, Neuroscience, Neuropeptide Y receptor and Receptor. His research in Endocrinology intersects with topics in Neuropeptide and Calcitonin gene-related peptide. In most of his Internal medicine studies, his work intersects topics such as Pharmacology.
He has researched Neuroscience in several fields, including Synaptic plasticity, Glutamatergic and Genetically modified mouse. His work carried out in the field of Neuropeptide Y receptor brings together such families of science as Behavioural despair test, Area postrema and Open field. Receptor is closely attributed to Binding site in his work.
Rémi Quirion focuses on Internal medicine, Endocrinology, Neuroscience, Pharmacology and Neuroprotection. His Internal medicine and Neuropeptide, Dopamine, Hippocampal formation, Receptor and Dopamine receptor investigations all form part of his Internal medicine research activities. His Receptor study combines topics from a wide range of disciplines, such as Behavioural despair test and Antidepressant.
His Endocrinology study combines topics in areas such as Calcitonin gene-related peptide, Neuropeptide Y receptor and Cell biology. His study in Neuroscience is interdisciplinary in nature, drawing from both Signal transduction and Neurodegeneration. The Pharmacology study combines topics in areas such as Sciatic nerve, Nerve injury and Receptor antagonist.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
Martin C. Michel;Annette Beck-Sickinger;Helen Cox;Henri N. Doods.
Pharmacological Reviews (1998)
International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors.
David R. Poyner;Patrick M. Sexton;Ian Marshall;David M. Smith.
Pharmacological Reviews (2002)
A proposal for the classification of sigma binding sites.
Rémi Quirion;Wayne D. Bowen;Yossef Itzhak;Jean Louis Junien.
Trends in Pharmacological Sciences (1992)
Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies
Daniel S Auld;Tom J Kornecook;Stéphane Bastianetto;Rémi Quirion.
Progress in Neurobiology (2002)
Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.
Judes Poirier;Marie Claude Delisle;Rémi Quirion;Isabelle Aubert.
Proceedings of the National Academy of Sciences of the United States of America (1995)
Autoradiographic localization of angiotensin II receptors in rat brain
Frederick A. O. Mendelsohn;Remi Quirion;Juan M. Saavedra;Greti Aguilera.
Proceedings of the National Academy of Sciences of the United States of America (1984)
Neuroanatomical Localization, Pharmacological Characterization and Functions of CGRP, Related Peptides and Their Receptors
D van Rossum;U K Hanisch;R Quirion.
Neuroscience & Biobehavioral Reviews (1997)
The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid.
Stéphane Bastianetto;Charles Ramassamy;Sylvain Doré;Yves Christen.
European Journal of Neuroscience (2000)
hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery.
T. Dennis;A. Fournier;A. Cadieux;F. Pomerleau.
Journal of Pharmacology and Experimental Therapeutics (1990)
The effects of chronic antidepressant treatment in an animal model of anxiety.
Shari R. Bodnoff;Shari R. Bodnoff;Barbara Suranyi-Cadotte;David H. Aitken;Remi Quirion.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: